title: Randomized comparison of imipenem/cilastatin and ceftazidime in the empiric therapy of severe abdominal infections. A multicenter study.
authors.forename: B
authors.initials: B
authors.lastname: Broze
authors.forename: J
authors.initials: J
authors.lastname: De Mees
authors.forename: R
authors.initials: R
authors.lastname: Droissart
authors.forename: V P
authors.initials: VP
authors.lastname: Nolens
authors.forename: J P
authors.initials: JP
authors.lastname: Staudt
authors.forename: M E
authors.initials: ME
authors.lastname: Verstraeten
authors.forename: P A
authors.initials: PA
authors.lastname: de Lame
mesh_terms: D001424:Bacterial Infections / Q000188:drug therapy*; D002442:Ceftazidime / Q000008:administration & dosage*; D015377:Cilastatin; D003521:Cyclopropanes / Q000008:administration & dosage*; D004066:Digestive System Diseases / Q000188:drug therapy; D004150:Dipeptidases / Q000037:antagonists & inhibitors*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D015378:Imipenem; D008795:Metronidazole / Q000008:administration & dosage; D011897:Random Allocation; D013845:Thienamycins / Q000008:administration & dosage*
chemical_list: D003521:Cyclopropanes; D013845:Thienamycins; D008795:Metronidazole; D015377:Cilastatin; D015378:Imipenem; D002442:Ceftazidime; D004150:Dipeptidases